Please let your Biosafety Officer know of ANY SARS-CoV-2 or COVID-19 related research you were approved to conduct by your PI, DLCI Head and MIT Administration, or are planning to submit. Most of the research involving recombinant parts of SARS-CoV-2, SARS-CoV (also referred to as SARS-CoV-1), or MERS-CoV requires registration with the CAB (MIT Committee on Assessment of Biohazards & Embryonic Stem Cell Research Oversight). Please plan accordingly and email BSP@mit.edu for a proper risk assessment.
The Occupational Safety and Health Administration’s Bloodborne Pathogens Standard, OSHA BBP Standard, was promulgated in 1991.The standard was issued to protect employees from occupational exposure to bloodborne pathogens, including but not limited to, the Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV). The regulation requires that employers have a written Exposure Control Plan (ECP) and that employees with occupational exposures to human materials understand how to prevent on-the-job exposures, be offered the Hepatitis B vaccine, and receive training prior to the start of any work, and annual re-training thereafter. Contact your Principal Investigator (PI) or supervisor to find out if your lab or group is included in the program.
Each lab or group with occupational exposure must have an Exposure Control Plan checklist and received training on their Exposure Control Plan (ECP) checklist.
Risk assessment: research involving the use of human blood, cells, tissues, organs, or cell lines regardless of testing for HIV & HBV (because of the potential for exposure to adventitious or unknown agents)
Please note that COUHES approval is required prior to the initiation of any research with human blood or tissues where the donor is identifiable.
Non-research: MIT Supervisors
The employee job description, responsibilities, and functions are used to make an assessment of potential exposures to human blood, tissues, organs, contaminated sharps or contaminated wastes and whether this potential exposure can be reasonably anticipated as part of the job.
Research: Principal Investigator
The Principal Investigator (PI) is responsible for developing a written plan that (1) identifies those aspects of the research that present risk of exposure to human materials and (2) outlines the way exposures to potentially infectious materials will be controlled. Exposures will be controlled through the use of personal protective equipment, procedures and equipment. The Biosafety Program (BSP) has a generic ECP checklist that is available here. PI’s are expected to tailor the generic ECP to their particular research project. The ECP must identify responsible individuals, where equipment is located, how it is to be used, and what to do in case of an exposure.
The supervisor is responsible for developing the ECP checklist which outlines the way exposures to potentially infectious materials will be controlled. Exposures will be controlled through the use of personal protective equipment and procedures. Supervisors are expected to fill in the ECP checklist (see template above)
BSP reviews the draft ECP checklist and recommends changes or clarifications. Once these have been incorporated into the ECP checklist, BSP will approve the ECP checklist. The approved ECP checklist is used as the basis for the subsequent training session
Research: Principal Investigator
All investigators, students and lab employees that will work with human materials must attend a training session at which the research risks and contents of the ECP checklist are explained, discussed and questions answered. Attendance at one of these sessions is required before the HBV vaccine can be offered. This session should take place before individuals begin work with human materials.
All at-risk employees must attend a training session at which the contents of the ECP checklist are explained, discussed and questions answered. Attendance at one of these sessions is required before the HBV vaccine can be offered. This session must take place before individuals begin work that involves potential exposure to human materials.
What training do I need to complete?
Bloodborne Pathogens Initial for Non-researchers or a bloodborne pathogens training that is specific to the employee’s job description, responsibilities and function, or job title. For more information about specific training contact us at BSP@mit.edu
Part of the training and information session is an explanation of the MIT HBV vaccination program. A form must be filled out at the session indicating whether the vaccination has been accepted or declined. Copies of these forms are forwarded to MIT Health. The vaccinations are free of charge. Individuals may decline the vaccine, then change their minds and receive the vaccine free of charge at any time.
Please contact the Biosafety Program at 2-3477 or bsp@mit.edu
The OSHA BBP Standard requires that the ECP checklist be reviewed and updated if necessary on an annual basis. Individuals covered by this standard must receive annual re-training. This re-training can be found on MIT Atlas Learning Center.
The Occupational Safety and Health Administration’s Bloodborne Pathogens Standard, OSHA BBP Standard, was promulgated in 1991.The standard was issued to protect employees from occupational exposure to bloodborne pathogens, including but not limited to, the Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV). The regulation requires that employers have a written Exposure Control Plan (ECP) and that employees with occupational exposures to human materials understand how to prevent on-the-job exposures, be offered the Hepatitis B vaccine, and receive training prior to the start of any work, and annual re-training thereafter. Contact your Principal Investigator (PI) or supervisor to find out if your lab or group is included in the program.
Each lab or group with occupational exposure must have an Exposure Control Plan checklist and received training on their Exposure Control Plan (ECP) checklist.
Risk assessment: research involving the use of human blood, cells, tissues, organs, or cell lines regardless of testing for HIV & HBV (because of the potential for exposure to adventitious or unknown agents)
Please note that COUHES approval is required prior to the initiation of any research with human blood or tissues where the donor is identifiable.
Non-research: MIT Supervisors
The employee job description, responsibilities, and functions are used to make an assessment of potential exposures to human blood, tissues, organs, contaminated sharps or contaminated wastes and whether this potential exposure can be reasonably anticipated as part of the job.
Research: Principal Investigator
The Principal Investigator (PI) is responsible for developing a written plan that (1) identifies those aspects of the research that present risk of exposure to human materials and (2) outlines the way exposures to potentially infectious materials will be controlled. Exposures will be controlled through the use of personal protective equipment, procedures and equipment. The Biosafety Program (BSP) has a generic ECP checklist that is available here. PI’s are expected to tailor the generic ECP to their particular research project. The ECP must identify responsible individuals, where equipment is located, how it is to be used, and what to do in case of an exposure.
The supervisor is responsible for developing the ECP checklist which outlines the way exposures to potentially infectious materials will be controlled. Exposures will be controlled through the use of personal protective equipment and procedures. Supervisors are expected to fill in the ECP checklist (see template above)
BSP reviews the draft ECP checklist and recommends changes or clarifications. Once these have been incorporated into the ECP checklist, BSP will approve the ECP checklist. The approved ECP checklist is used as the basis for the subsequent training session
Research: Principal Investigator
All investigators, students and lab employees that will work with human materials must attend a training session at which the research risks and contents of the ECP checklist are explained, discussed and questions answered. Attendance at one of these sessions is required before the HBV vaccine can be offered. This session should take place before individuals begin work with human materials.
All at-risk employees must attend a training session at which the contents of the ECP checklist are explained, discussed and questions answered. Attendance at one of these sessions is required before the HBV vaccine can be offered. This session must take place before individuals begin work that involves potential exposure to human materials.
What training do I need to complete?
Bloodborne Pathogens Initial for Non-researchers or a bloodborne pathogens training that is specific to the employee’s job description, responsibilities and function, or job title. For more information about specific training contact us at BSP@mit.edu
Part of the training and information session is an explanation of the MIT HBV vaccination program. A form must be filled out at the session indicating whether the vaccination has been accepted or declined. Copies of these forms are forwarded to MIT Health. The vaccinations are free of charge. Individuals may decline the vaccine, then change their minds and receive the vaccine free of charge at any time.
Please contact the Biosafety Program at 2-3477 or bsp@mit.edu
The OSHA BBP Standard requires that the ECP checklist be reviewed and updated if necessary on an annual basis. Individuals covered by this standard must receive annual re-training. This re-training can be found on MIT Atlas Learning Center.
